University of Helsinki
Overview
University of Helsinki is the venture investment arm of the university, focusing on pre-seed and seed stage investments in research-based spinouts and startups with a clear connection to the institution. Its technology transfer office, Helsinki Innovation Services (HIS), manages the commercialization pipeline for these ventures.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| GlucoModicum | Apr 2018 | Pre Seed | Co-investor |
| Acouspin | Jan 2025 | Pre Seed | Co-investor |
| Perfat Technologies | Sep 2025 | Series A | Co-investor |
| Avenue Biosciences | Jan 2026 | Seed | Co-investor |
Key People
Chris Heyer
Science Partnership with Marvelous Advisor & Mentor
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is University of Helsinki based?
University of Helsinki is headquartered in Helsinki, Finland.
When was University of Helsinki founded?
University of Helsinki was founded in 2000.
How many portfolio companies does University of Helsinki have?
University of Helsinki has 4 portfolio companies in Caplight's dataset.
What are some companies in University of Helsinki's portfolio?
Portfolio companies visible on Caplight include GlucoModicum, Acouspin, Perfat Technologies, Avenue Biosciences.
What was University of Helsinki's most recent investment shown here?
University of Helsinki's most recent investment in this portfolio sample was in Avenue Biosciences in 2026.
What sectors does University of Helsinki focus on?
University of Helsinki focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Frontier & Industrial Tech, Energy & Sustainability, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure, Frontier & Industrial Tech.
What company stages does University of Helsinki focus on?
University of Helsinki typically invests at the Early stage.
What is University of Helsinki's AUM?
University of Helsinki's assets under management are estimated between $41.4M and $91.5M.